SERASera Prognostics Inc. Class A Common Stock
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM t…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Sera (SERA) Q2 2026 Earnings Call Transcript Illinois Medicaid coverage for PreTRM test unlocks 50,000 annual births as payer access expands. | ||
 Sera Prognostics, Inc. Q2 2026 Earnings Call Summary Moby summary of Sera Prognostics, Inc.'s Q2 2026 earnings call | ||
Sera Prognostics Inc (SERA) (Q2 2026) Earnings Call Highlights: Payer Momentum Builds with ... Despite minimal revenue, Sera Prognostics advances commercial strategy with new payer programs and a strengthened cash runway through 2029. | ||
 Sera Prognostics Q2 Earnings Call Highlights Sera Prognostics (NASDAQ:SERA) reported modest second-quarter revenue while outlining progress in payer engagement, Illinois Medicaid policy, clinical evidence and European regulatory preparations for its PreTRM Test-guided care platform. Revenue for the quarter ended June 30 was $30,000, compared | ||
 Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Misses Revenue Estimates Sera Prognostics (SERA) delivered earnings and revenue surprises of -28.57% and -76.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates Viatris (VTRS) delivered earnings and revenue surprises of +11.29% and +2.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Sera Prognostics (SERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. | ||
 Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely? There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com... | ||